. Existing markers for prostate cancer, such as prostate-specific antigen (PSA), have limitations in
termsMukhametov, Ural,
Lyulin, Sergey,
Borzunov, Dmitry,
Ilyasova, Tatiana,
Gareev, Ilgiz,
Sufianov, Albert (2023) at the stages of surgical
treatment (the nearest post-traumatic period and long-
term periods) in the absence